(Q43989705)

28 November 2017

title

Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis (English)

1 reference

28 November 2017

0 references

1 reference

1 reference

Schaad UB

1

1 reference

28 November 2017

Wedgwood-Krucko J

series ordinal

2

1 reference

28 November 2017

Suter S

series ordinal

3

1 reference

28 November 2017

Kraemer R

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

The Journal of Pediatrics

28 November 2017

published in

1 reference

28 November 2017

volume

111

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

599-605

1 reference

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antibiotic use in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antibiotic therapy in cystic fibrosis: evaluation of clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Assay of ceftazidime in biological fluids using high-pressure liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

The systematic evaluation of the chest radiograph in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Reversibility of lung function abnormalities in children with perennial asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Cephalosporin therapeutics in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Pulmonary deposition of aerosols in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

The art and science of the use of antibiotics in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980130-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(87)80130-0

1 reference

28 November 2017

1 reference